{
    "code": "60001041",
    "url": "https:\/\/info.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=60001041",
    "time": "2023-12-07 19:50:26",
    "許可證字號": "衛部菌疫輸字第001041號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "製造許可登錄編號": "",
    "有效日期": "116\/03\/21",
    "發證\/登錄日期": "106\/03\/21",
    "許可證\/登錄種類": "菌　疫",
    "舊證字號": "",
    "醫療器材級數": "",
    "第一等級醫療器材原許可證字號": "",
    "第一等級醫療器材新登錄字號": "",
    "通關簽審文件編號": "DHA06000104101",
    "中文品名": "達栓普注射液\/輸注液",
    "英文品名": "Praxbind Solution for injection\/infusion",
    "適應症": "Praxbind屬於一種專一性的dabigatran反轉作用劑，適用於接受普栓達(Pradaxa)治療而需要快速反轉dabigatran抗凝血作用的成人病患：\r\n1.供緊急手術\/緊急程序(urgent procedures)使用。\r\n2.於威脅生命或控制不良的出血時使用。",
    "劑型": "270注射劑",
    "包裝": "2玻璃小瓶裝 盒裝",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "05限由醫師使用",
    "管制藥品分類級別": "",
    "藥品分類": "",
    "監視期限": "111\/03\/21",
    "主成分略述": "Idarucizumab",
    "限制項目": "02輸　入 5F免除銜接性試驗",
    "申請商名稱": "台灣百靈佳殷格翰股份有限公司",
    "申請商地址": "台北市中山區民生東路三段2號12樓",
    "主製造廠": [
        {
            "製造廠名稱": "BOEHRINGER INGELHEIM PHARMA GMBH &amp; CO. KG",
            "製造廠廠址": "BIRKENDORFER STRASSE 65, 88397 BIBERACH AN DER RISS, GERMANY",
            "製造廠公司地址": "BINGER STRASSE 173, 55216 INGELHEIM AM RHEIN, GERMANY",
            "製造廠國別": "GERMANY",
            "製程": "原料藥及成品製造廠"
        }
    ],
    "次製造廠": [
        {
            "製造廠名稱": "BOEHRINGER INGELHEIM INTERNATIONAL GMBH",
            "製造廠廠址": "INGELHEIM AM RHEIN GERMANY",
            "製造廠公司地址": "",
            "製造廠國別": "GERMANY",
            "製程": "許可證持有者"
        }
    ],
    "CCC號列": "",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "6400001800",
            "成分名稱": "Idarucizumab",
            "含量描述": "",
            "含量": "2500.0000000000",
            "單位": "MG"
        }
    ],
    "仿單外盒": [
        {
            "title": "020010410001-108-11-01.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=60001041&Seq=004&Type=9"
        },
        {
            "title": "020010410001-107-11-05.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=60001041&Seq=003&Type=9"
        },
        {
            "title": "LA-P038341-002-110-02-09(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=60001041&Seq=004&Type=8"
        },
        {
            "title": "PXB_FBP038342-002-108-06-12(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=60001041&Seq=003&Type=8"
        },
        {
            "title": "衛部菌疫輸字第001041號 達栓普®注射液輸注液(標籤)-106-04-13.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=60001041&Seq=002&Type=8"
        },
        {
            "title": "衛部菌疫輸字第001041號 達栓普®注射液輸注液(盒子)-106-04-13.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=60001041&Seq=001&Type=8"
        }
    ]
}